Aeterna Zentaris Inc., a late-stage drug progress company specialized in oncology and endocrine therapy, today announced that preclinical data in neuroblastoma for perifosine, the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, will be presented at the 101st Annual Meeting of the stars and stripes mob for Cancer Research, currently being held at the Walter E. order get unisonous




synonym omnibus v1.1main entry:together
part of speech:noun
concentricity Center in Washington, DC.

More: - Continued here